Andrew Stefka
University of Chicago
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andrew Stefka.
Proceedings of the National Academy of Sciences of the United States of America | 2014
Andrew Stefka; Taylor Feehley; Prabhanshu Tripathi; Ju Qiu; Kathleen McCoy; Sarkis K. Mazmanian; Melissa Y Tjota; Goo-Young Seo; Severine Cao; Betty Theriault; Dionysios A. Antonopoulos; Liang Zhou; Eugene B. Chang; Yang-Xin Fu; Cathryn R. Nagler
Significance The prevalence of food allergy is rising at an alarming rate; the US Centers for Disease Control and Prevention documented an 18% increase among children in the United States between 1997 and 2007. Twenty-first century environmental interventions are implicated by this dramatic generational increase. In this report we examine how alterations in the trillions of commensal bacteria that normally populate the gastrointestinal tract influence allergic responses to food. We identify a bacterial community that protects against sensitization and describe the mechanism by which these bacteria regulate epithelial permeability to food allergens. Our data support the development of novel adjunctive probiotic therapies to potentiate the induction of tolerance to dietary allergens. Environmentally induced alterations in the commensal microbiota have been implicated in the increasing prevalence of food allergy. We show here that sensitization to a food allergen is increased in mice that have been treated with antibiotics or are devoid of a commensal microbiota. By selectively colonizing gnotobiotic mice, we demonstrate that the allergy-protective capacity is conferred by a Clostridia-containing microbiota. Microarray analysis of intestinal epithelial cells from gnotobiotic mice revealed a previously unidentified mechanism by which Clostridia regulate innate lymphoid cell function and intestinal epithelial permeability to protect against allergen sensitization. Our findings will inform the development of novel approaches to prevent or treat food allergy based on modulating the composition of the intestinal microbiota.
The ISME Journal | 2016
Roberto Berni Canani; Naseer Sangwan; Andrew Stefka; Rita Nocerino; Lorella Paparo; Rosita Aitoro; Antonio Calignano; Aly A. Khan; Jack A. Gilbert; Cathryn R. Nagler
Dietary intervention with extensively hydrolyzed casein formula supplemented with Lactobacillus rhamnosus GG (EHCF+LGG) accelerates tolerance acquisition in infants with cow’s milk allergy (CMA). We examined whether this effect is attributable, at least in part, to an influence on the gut microbiota. Fecal samples from healthy controls (n=20) and from CMA infants (n=19) before and after treatment with EHCF with (n=12) and without (n=7) supplementation with LGG were compared by 16S rRNA-based operational taxonomic unit clustering and oligotyping. Differential feature selection and generalized linear model fitting revealed that the CMA infants have a diverse gut microbial community structure dominated by Lachnospiraceae (20.5±9.7%) and Ruminococcaceae (16.2±9.1%). Blautia, Roseburia and Coprococcus were significantly enriched following treatment with EHCF and LGG, but only one genus, Oscillospira, was significantly different between infants that became tolerant and those that remained allergic. However, most tolerant infants showed a significant increase in fecal butyrate levels, and those taxa that were significantly enriched in these samples, Blautia and Roseburia, exhibited specific strain-level demarcations between tolerant and allergic infants. Our data suggest that EHCF+LGG promotes tolerance in infants with CMA, in part, by influencing the strain-level bacterial community structure of the infant gut.
Gastroenterology | 2009
Kabir S. Matharu; Emiko Mizoguchi; Carmen Alonso Cotoner; Deanna D. Nguyen; Bethany Mingle; Onyinye I. Iweala; Megan E. McBee; Andrew Stefka; Guenolee Prioult; Kevin M. Haigis; Atul K. Bhan; Scott B. Snapper; Hidehiro Murakami; David B. Schauer; Hans-Christian Reinecker; Atsushi Mizoguchi; Cathryn R. Nagler
BACKGROUND & AIMS The commensal microbiota is believed to have an important role in regulating immune responsiveness and preventing intestinal inflammation. Intestinal microbes produce signals that regulate inflammation via Toll-like receptor (TLR) signaling, but the mechanisms of this process are poorly understood. We investigated the role of the anti-inflammatory cytokine interleukin (IL)-10 in this signaling pathway using a mouse model of colitis. METHODS Clinical, histopathologic, and functional parameters of intestinal inflammation were evaluated in TLR4(-/-), IL-10(-/-), and TLR4(-/-) x IL-10(-/-) mice that were free of specific pathogens and in TLR4(-/-) x IL-10(-/-) mice following eradication and reintroduction of Helicobacter hepaticus. Regulatory T-cell (Treg) function was evaluated by crossing each of the lines with transgenic mice that express green fluorescent protein under control of the endogenous regulatory elements of Foxp3. Apoptotic cells in the colonic lamina propria were detected by a TUNEL assay. RESULTS TLR4-mediated signals have 2 interrelated roles in promoting inflammation in TLR4(-/-) x IL-10(-/-) mice. In the absence of TLR4-mediated signals, secretion of proinflammatory and immunoregulatory cytokines is dysregulated. Tregs (Foxp3(+)) that secrete interferon-gamma and IL-17 accumulate in the colonic lamina propria of TLR4(-/-) x IL-10(-/-) mice and do not prevent inflammation. Aberrant control of epithelial cell turnover results in the persistence of antigen-presenting cells that contain apoptotic epithelial fragments in the colonic lamina propria of Helicobacter-infected TLR4(-/-) mice. CONCLUSIONS In mice that lack both IL-10- and TLR4-mediated signals, aberrant regulatory T-cell function and dysregulated control of epithelial homeostasis combine to exacerbate intestinal inflammation.
Science | 2017
Yun Gi Kim; Kei Sakamoto; Sang Uk Seo; Joseph M. Pickard; Merritt Gillilland; Nicholas A. Pudlo; Matthew Hoostal; Xue Li; Thomas D. Wang; Taylor Feehley; Andrew Stefka; Thomas M. Schmidt; Eric C. Martens; Shinji Fukuda; Naohiro Inohara; Cathryn R. Nagler; Gabriel Núñez
Gut anaerobes protect against pathogen invasion Intestinal infections are a common problem for young animals. One explanation is that the protective gut microbiota is not fully established in infants. How the microbiota might protect against pathogens is unclear. Kim et al. found that members of the group of strictly anaerobic, spore-forming bacteria known as clostridia protect neonatal mice against diarrhea-causing pathogens. The protective effect is enhanced by giving mice the metabolite succinate in drinking water. Succinate favors colonization of the neonatal gut by cluster IV and XIVa clostridia and concomitantly excludes Salmonella typhimurium. Science, this issue p. 315 Establishment of benign anaerobic gut microbiota can be boosted by succinate to protect infant guts from pathogen invasion. The high susceptibility of neonates to infections has been assumed to be due to immaturity of the immune system, but the mechanism remains unclear. By colonizing adult germ-free mice with the cecal contents of neonatal and adult mice, we show that the neonatal microbiota is unable to prevent colonization by two bacterial pathogens that cause mortality in neonates. The lack of colonization resistance occurred when Clostridiales were absent in the neonatal microbiota. Administration of Clostridiales, but not Bacteroidales, protected neonatal mice from pathogen infection and abrogated intestinal pathology upon pathogen challenge. Depletion of Clostridiales also abolished colonization resistance in adult mice. The neonatal bacteria enhanced the ability of protective Clostridiales to colonize the gut.
Seminars in Immunopathology | 2012
Taylor Feehley; Andrew Stefka; Severine Cao; Cathryn R. Nagler
The incidence of food allergy in developed countries is rising at a rate that cannot be attributed to genetic variation alone. In this review, we discuss the environmental factors that may contribute to the increasing prevalence of potentially fatal anaphylactic responses to food. Decreased exposure to enteric infections due to advances in vaccination and sanitation, along with the adoption of high-fat (Western) diets, antibiotic use, Cesarean birth, and formula feeding of infants, have all been implicated in altering the enteric microbiome away from its ancestral state. This collection of resident commensal microbes performs many important physiological functions and plays a central role in the development of the immune system. We hypothesize that alterations in the microbiome interfere with immune system maturation, resulting in impairment of IgA production, reduced abundance of regulatory T cells, and Th2-skewing of baseline immune responses which drive aberrant responses to innocuous (food) antigens.
Journal of Clinical Investigation | 2016
Yuk Man Lei; Luqiu Chen; Ying Wang; Andrew Stefka; Luciana Molinero; Betty Theriault; Keston Aquino-Michaels; Ayelet Sivan; Cathryn R. Nagler; Thomas F. Gajewski; Anita S. Chong; Caroline Bartman; Maria-Luisa Alegre
Transplantation is the only cure for end-stage organ failure, but without immunosuppression, T cells rapidly reject allografts. While genetic disparities between donor and recipient are major determinants of the kinetics of transplant rejection, little is known about the contribution of environmental factors. Because colonized organs have worse transplant outcome than sterile organs, we tested the influence of host and donor microbiota on skin transplant rejection. Compared with untreated conventional mice, pretreatment of donors and recipients with broad-spectrum antibiotics (Abx) or use of germ-free (GF) donors and recipients resulted in prolonged survival of minor antigen-mismatched skin grafts. Increased graft survival correlated with reduced type I IFN signaling in antigen-presenting cells (APCs) and decreased priming of alloreactive T cells. Colonization of GF mice with fecal material from untreated conventional mice, but not from Abx-pretreated mice, enhanced the ability of APCs to prime alloreactive T cells and accelerated graft rejection, suggesting that alloimmunity is modulated by the composition of microbiota rather than the quantity of bacteria. Abx pretreatment of conventional mice also delayed rejection of major antigen-mismatched skin and MHC class II-mismatched cardiac allografts. This study demonstrates that Abx pretreatment prolongs graft survival, suggesting that targeting microbial constituents is a potential therapeutic strategy for enhancing graft acceptance.
Journal of Leukocyte Biology | 2014
Anthony T. Cao; Suxia Yao; Andrew Stefka; Zhanju Liu; Hongwei Qin; Houpu Liu; Heather L. Evans-Marin; Charles O. Elson; Cathryn R. Nagler; Yingzi Cong
Tregs play a crucial role in the maintenance of intestinal immune homeostasis. However, significant numbers of Foxp3+ Tregs accumulate in the inflamed lesions in experimental colitis and in IBD patients. Treg production of the proinflammatory cytokines IFN‐γ and/or IL‐17 may arguably explain their ineffectiveness in suppressing intestinal inflammation. However, it remains unknown whether iTreg and tTreg produce proinflammatory cytokines and how TLR signaling regulates this process. Here, we found that Foxp3+Tregs were increased in the intestines of B6.TLR4−/− and B6.IL‐10−/− mice when compared with WT B6 mice. TLR4−/− and IL‐10−/− resulted in more Tregs within inflamed intestines. The majority of Foxp3+ Tregs in the spleen was Helios+Nrp1+, whereas most Foxp3+ Tregs in the intestinal LP were Helios−Nrp1−. More Helios+Nrp1+ Tregs expressed IFN‐γ and/or IL‐17 than did Helios−Nrp1− Tregs in the spleen and intestine, which was increased with TLR4−/−. TLR4 signaling in T cells and APCs inhibited Foxp3+ induction via MyD88‐dependent, TRIF‐independent pathways, which was negatively regulated by SOCS3. Collectively, these data demonstrate Helios+Nrp1+ tTregs and Helios−Nrp1− iTregs produce proinflammatory cytokines in the intestines during inflammation, which was regulated by TLR4 signaling.
Blood | 2016
Todd M. Zimmerman; Noopur Raje; Ravi Vij; Donna E. Reece; Jesus G. Berdeja; Leonor A Stephens; Kathryn McDonnell; Cara A. Rosenbaum; Jagoda Jasielec; Paul G. Richardson; Sandeep Gurbuxani; Jennifer Nam; Erica Severson; Brittany Wolfe; Shaun Rosebeck; Andrew Stefka; Dominik Dytfeld; Kent A. Griffith; Andrzej J. Jakubowiak
Digestive and Liver Disease | 2014
Margherita Di Costanzo; Rosita Aitoro; Lorella Paparo; Andrew Stefka; Tiffany Patton; Rita Nocerino; Antonio Calignano; Rosaria Meli; Giuseppina Mattace Raso; Raffaele Simeoli; Stefano Guandalini; Cathryn R. Nagler; Roberto Berni Canani
Journal of Immunology | 2013
Anthony T. Cao; Suxia Yao; Andrew Stefka; Hongwei Qin; Charles O. Elson; Cathryn R. Nagler; Yingzi Cong